Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
4
Number of overlapping holdings
16.0%
% of BBH's 27 holdings also in IBRN
10.5%
% of IBRN's 54 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBH |
Weight in IBRN |
Overlap | |
---|---|---|---|---|
BIOGEN IDEC INC | 4.6% | 4.7% | 4.6% | |
ARGENX SE ADR | 4.3% | 4.5% | 4.3% | |
NEUROCRINE BIOSCIENCES INC | 2.7% | 4.9% | 2.7% | |
SAREPTA THERAPEUTICS INC | 2.5% | 4.8% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to IBRN
AMGEN INC | 16.4% | |
VERTEX PHARMACEUTICALS INC | 9.6% | |
REGENERON PHARMACEUTICALS | 7.9% | |
GILEAD SCIENCES INC | 7.4% | |
MODERNA, INC. | 6.0% | |
IQVIA HOLDINGS INC | 4.6% | |
ICON PLC | 4.2% | |
ILLUMINA INC | 3.6% | |
BEIGENE LTD. SPONSORED ADR | 3.2% | |
BIOMARIN PHARMACEUTICAL INC | 2.6% |
BBH Underweight Relative to IBRN
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% | |
PTC THERAPEUTICS INC | -4.7% | |
AXONICS MODULATION TECHNOLOGIES, INC | -4.7% | |
INTRA-CELLULAR THERAPIES INC | -4.3% | |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% | |
ALKERMES PLC | -3.7% | |
INTEGRA LIFESCIENCES HOLDING | -3.4% | |
CATALYST PHARMACEUTICAL PART | -3.3% | |
SUPERNUS PHARMACEUTICALS INC | -3.1% | |
ACADIA PHARMACEUTICALS INC | -3.0% |